Skip to main content
. 2026 Jan 30;16(1):e110772. doi: 10.1136/bmjopen-2025-110772

Table 3. Baseline data description.

Variables Number of participants
N=3931
Age (years), mean SD 72.1±15.1
Sex, female, N (%) 1806 (45.9%)
Ethnic origin, N (%)
 White 2365 (60.2%)
 Black 649 (16.5%)
 Asian 511 (13%)
 Other 216 (5.5%)
 Not known 190 (4.8%)
Stroke type, N (%)
 Ischaemic stroke 3371 (85.8%)
 Intracerebral haemorrhage 560 (14.2%)
Medical history, N (%)
 History of stroke/TIA 703 (17.9%)
 Hypertension 2506 (63.7%)
 AF 956 (24.3%)
 Heart failure (3929 complete) 183 (4.7%)
 Diabetes mellitus 1034 (26.3%)
Acute treatments
 Thrombolysis (3930 complete) 616 (18.1%)
 Thrombectomy 294 (7.5%)
Clinical features, N (%)
 Admission NIHSS 0–3 1688 (43.0%)
 Admission NIHSS ≥4 2240 (57.0%)
 Premorbid mRS 3931 (100%)
 Discharge mRS 3931 (100%)
 Discharge mRS, median (IQR)
Brain imaging, N (%)
 CT (at UCLH) 3596 (95.6%)
 CTA (at UCLH) 2231 (62%)
 MRI (at UCLH) 2234 (57%)
 MRA (at UCLH) 368 (16.5%)

Table showing baseline characteristics and completeness of clinical and brain imaging data.

AF, atrial fibrillation; CTA, CT angiography; ESD, early supported discharge; MRA, magnetic resonance angiography; mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Severity Scale; TIA, transient ischaemic attack; UCLH, University College London Hospitals.